Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-products/trac-tecan-robotic-assay-composer-from-tecan-1715-1/;msg90356) was not found.

Search biology products trac tecan robotic assay composer from tecan 1715 1 ;msg90356 at Google

Search biology products trac tecan robotic assay composer from tecan 1715 1 ;msg90356 at Yahoo

Search biology products trac tecan robotic assay composer from tecan 1715 1 ;msg90356 at Msn

Google
 
(Date:12/2/2009)...acculturated Latino men have a more difficult time...ated to U.S. culture, but acculturation has no aff...f these findings are published in Cancer Epidemio...merican Association for Cancer Research. The Decem...lturation affects smoking cessation differently fo...
(Date:12/2/2009)...e who smoke their first cigarette within minutes a..., a by-product of nicotine when processed by the b...he number of cigarettes smoked. , "Since cotin...er, our results suggest that smokers who smoke imm...r lung cancer," said researcher Joshua E. Muscat, ...
(Date:12/2/2009)...nce of a cancer-free status did not prompt people ...hy (CT) lung-cancer screening program to pick up t...y published in Cancer Epidemiology, Biomarkers & ... for Cancer Research. The December issue contains ...ld negate widespread concern in the lung screening...
Breaking Biology News(10 mins):Acculturation affects smoking cessation success among Latinos 2Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Advanced Heart Procedure Treats Growing Problem 51120 1Advanced Heart Procedure Treats Growing Problem 51120 2Advanced Heart Procedure Treats Growing Problem 51120 3Screen All Newborns for Hip Dysplasia Study Urges 51115 1Screen All Newborns for Hip Dysplasia Study Urges 51115 2B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 1B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 2B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 3B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 4B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 5B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 6
(Date:12/5/2009)... advanced Technology Center helps companies develo...y available to the lab allows it to work in a vari... relating to cleaning parts, process development, ...s) December 5, 2009 -- Midbrook, Inc , a Jackson,...gy center laboratory that performs a wide variety ...
(Date:12/4/2009)...ent Trust Inc. (NYSE: CRE ) ("Care" or the "Com... has declared a dividend of $0.17 per share of com..., 2009 to common shareholders of record on Decembe... Care Investment Trust Inc. is a real estate inves...related real estate and commercial mortgage debt. ...
(Date:12/4/2009)...lthcare Trust of America, Inc. ("HTA"), a self-man...nounced the execution of a purchase and sale agree...rtfolio located in San Angelo, Texas, Corsicana, T...0,500,000. The closing of the acquisition is subj... ,, The approximately 92,500 square foot portfolio...
(Date:12/4/2009)...se to the U.S. Justice Department Drug Enforcement...methyltestosterone, and 19-nor-4,9(10)-androstadie...ed Substances Act (CSA), John Gay, executive direc...PA), the oldest and largest trade association rep...upplements and other natural products, issued the ...
(Date:12/4/2009)...re recruited annually to participate in clinical t... Protection (AHRP), and most will be compensated f...ns view payments to volunteers as compensation for...ial risks related to participating in the experime...very different view of clinical trial compensation...
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2
IMAGEQUANT 400 WKSTN from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-Human IFN-Alpha / Beta R2 (IFNAR2) (CD118) Neutralizing Polyclonal Antibody, Unconjugated from PBL InterferonSource
Rabbit Anti-MYCOBACTERIUM TUBERCULOSIS Polyclonal Antibody, Unconjugated from AbD Serotec
ImageQuant 400 from GE Healthcare, formerly Amersham Biosciences
Biology Products:
Lambert Rake Membrane Spatula
Olk Angled Retinal Spatula - 110 Degree
Castroviejo Cyclodialysis Spatula
Cleasby Iris Spatula
Medicine Products:
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/2/2009)HOBOKEN, N.J., Dec. 2 According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopat
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
(Date:12/4/2009)...emistry World recently highlighted a new report ...ufacturers of America ( PhRMA ) that identifies 9...DS and related conditions. ,, The report found t...ines and 54 antivirals. These drugs are either in ...U.S. Food and Drug Administration ( FDA ). ,, &quo...
(Date:12/4/2009)...e, Inc. (NYSE Amex: PIP ), a biodefense company d...al and chemical threats, announced today that the ...ting the effectiveness of Valortim® in an inh...W) rabbit. The data are being presented during an...edical Countermeasures Enterprise (PHEMCE) Stakeho...
(Date:12/4/2009)...rthoAccel Technologies, Inc., developers of the A... to enhance orthodontics, announced the availabili...by PennWell Corporation , a leader in professiona...e and dentistry. The course focuses on patient vi...tment biomechanics, factors that increase treatmen...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4LSUHSC research helps link schizophrenia to specific DNA region 9175 1LSUHSC research helps link schizophrenia to specific DNA region 9175 2UCI Medical Affiliates Inc s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 51103 1UCI Medical Affiliates Inc s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 51103 2UCI Medical Affiliates Inc s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 51103 3UCI Medical Affiliates Inc s Internal Investigation Leads to SEC Action and Criminal Charges Against Former Executive Officer 51103 4Telerent Leasing Corporation Recognized with Monitors Top 100 Award 51098 1Telerent Leasing Corporation Recognized with Monitors Top 100 Award 51098 2